Pharmafile Logo
Pharmafocus logo
Advanced Search

R&D

Showing 15 posts of 146 posts found.

Novartis R&D: looking for the ‘Sweet Spot’

August 27, 2013
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, R&D, Vasella

Feature
syntaxin image

Ipsen buys Syntaxin

July 16, 2013
Research and Development, Sales and Marketing R&D, ipsen, neurology, syntaxin, tsi

French pharma group Ipsen has snapped up privately-owned UK life sciences firm Syntaxin for an upfront payment of €28 million …

News
Sanofi image

Sanofi makes Curie cancer deal

June 20, 2013
Research and Development, Sales and Marketing Cancer, R&D, Sanofi, curie

Sanofi has signed a three-year research collaboration with the Curie Institute to identify new therapeutic targets which will help develop …

News

John LaMattina: India’s solution to drug costs

May 13, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing India, LaMattina, R&D

Drug pricing is a major issue in India. The Indian government believes that the prices of lifesaving drugs shouldn’t be …

Feature
astrazeneca image

AstraZeneca reveals Alderley Park plan

May 8, 2013
Research and Development, Sales and Marketing AstraZeneca, BioCity, R&D, alderley

AstraZeneca has left a key question about what to do with its soon-to-be defunct R&D site in Cheshire in the …

News

Pharma R&D ‘untenable’

April 25, 2013
Research and Development, Sales and Marketing GlobalData, R&D

The current model by which pharma carries out R&D is ‘untenable’, according to a new report. But the research, from …

News
Astrazeneca image

AstraZeneca sets out growth strategy

March 21, 2013
Sales and Marketing AstraZeneca, R&D

AstraZeneca has set out an ambitious plan designed to return it to growth which eschews diversification and sets great store …

News
Astrazeneca image

AstraZeneca restructures global R&D

March 19, 2013
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, R&D

AstraZeneca is restructuring its global operations in a bid to improve the productivity of its R&D operations. The firm is …

News
Records image

NHS patient data and clinical research – coming together at last?

January 28, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, NHS, R&D, clinical, records, transparency

In the mid-1990s, an NHS teaching hospital close to my offices invited proposals for expanding its clinical trials unit. Hitherto …

Feature
cell vaccine image

Vaccine manufacturing emerges as outsourcing market

January 28, 2013
Manufacturing and Production R&D, Vaccine, outsourcing

Healthy growth in the market for vaccines – coupled with high production costs – look set to create a vaccine …

News
Astrazeneca image

AstraZeneca shakes up management

January 16, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Mackay, R&D, Soriot

AstraZeneca has taken its most dramatic steps yet to arrest decline, with chief executive Pascal Soriot axeing two senior positions …

News

R&D costs rise ten-fold

December 4, 2012
Research and Development, Sales and Marketing OHE, R&D, research and development

Research by the Office of Health Economics (OHE) think tank shows that the cost of pharma R&D has risen ten-fold …

News
ABPI image

UK medicine costs ‘under control’

October 24, 2012
Sales and Marketing ABPI, PCT, R&D, UK medicine

The ABPI has seized on two reports – one its own and one independent – published this week to assert …

News

Turkey ‘can be pharma R&D, production hub by 2023’, says PwC

October 23, 2012
Manufacturing and Production, Research and Development, Sales and Marketing R&D, Turkey, pwC

Despite lagging behind its peers among ‘pharmerging’ economies, Turkey has the potential to become a major R&D and production hub …

News
Novo Nordisk image

Novo Nordisk to expand Beijing R&D centre

September 25, 2012
Research and Development, Sales and Marketing Beijing, China, Novo Nordisk, R&D

Novo Nordisk is investing $100 million into enlarging its R&D facilities in Beijing into a state-of-the-art centre. Located in the …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026